N
KRTX

Nuveen’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Nuveen’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-134,791
Closed -$42.7M – 3318
2023
Q4 		$42.7M Sell
134,791
-25,782
-16% -$5.01M 0.01% 680
2023
Q3 		$27.2M Buy
160,573
+10,275
+7% +$1.93M 0.01% 860
2023
Q2 		$32.6M Buy
150,298
+3,071
+2% +$658K 0.01% 771
2023
Q1 		$26.7M Buy
147,227
+37,370
+34% +$7.15M 0.01% 857
2022
Q4 		$21.6M Buy
109,857
+12,871
+13% +$2.76M 0.01% 985
2022
Q3 		$21.8M Buy
96,986
+21,681
+29% +$4.39M 0.01% 952
2022
Q2 		$1.33M Buy
75,305
+9,848
+15% +$1.13M ﹤0.01% 2659
2022
Q1 		$1.16M Sell
65,457
-536
-0.8% -$60.3K ﹤0.01% 2760
2021
Q4 		$1.17M Sell
65,993
-6,030
-8% -$779K ﹤0.01% 2805
2021
Q3 		$1.27M Sell
72,023
-13,155
-15% -$1.52M ﹤0.01% 2887
2021
Q2 		$1.51M Buy
85,178
+16,881
+25% +$1.97M ﹤0.01% 2831
2021
Q1 		$1.21M Sell
68,297
-469
-0.7% -$53.1K ﹤0.01% 2831
2020
Q4 		$1.22M Sell
68,766
-1,774
-3% -$164K ﹤0.01% 2736
2020
Q3 		$1.25M Sell
70,540
-1,883
-3% -$160K ﹤0.01% 2596
2020
Q2 		$1.28M Buy
72,423
+27,392
+61% +$2.38M ﹤0.01% 2516
2020
Q1 		$3.24M Buy
45,031
+22,538
+100% +$1.93M ﹤0.01% 1945
2019
Q4 		$1.7M Buy
+22,493
New +$985K ﹤0.01% 2492

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Nuveen's KRTX Position: Q1 2024 in Review

Nuveen sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 134,791 shares — an estimated $42.7M sold.

Nuveen first reported a position in KRTX in Q4 2019 and held it in 17 quarters. The position peaked at $42.7M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Nuveen reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Nuveen sold 134,791 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $42.7M.
  • Nuveen first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 17 quarters.
  • Nuveen's Karuna Therapeutics, Inc. Common Stock position peaked at $42.7M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Nuveen's 13F filing for Q1 2024, filed 13 May 2024.